1 – 10 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
(
- Contribution to journal › Article
-
Mark
Plasma pro-inflammatory cytokines, IgM-uria and cardiovascular events in patients with chest pain: A comparative study.
(
- Contribution to journal › Article
- 2013
-
Mark
Increased urinary IgM excretion in patients with chest pain due to coronary artery disease
(
- Contribution to journal › Article
- 2010
-
Mark
Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
The response to antihypertensive therapy is dependent on renal structural changes. A 5-year prospective study of renal biopsy in type 2 diabetic patients with micro-macroalbuminuria.
(
- Contribution to journal › Article
- 2009
-
Mark
Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
(
- Contribution to journal › Article
-
Mark
Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy.
(
- Contribution to journal › Article
- 2007
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
-
Mark
Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden.
(
- Contribution to journal › Article
-
Mark
Sight-threatening retinopathy is associated with lower mortality in type 2 diabetic subjects: A 10-year observation study.
(
- Contribution to journal › Article